{
    "pmcid": "10757926",
    "qa_pairs": {
        "How does the paper suggest nanobodies could be used in relation to the SARS-CoV-2 spike protein?": [
            "As both therapeutic agents to block the spike protein's interaction with ACE2 and diagnostic tools to detect viral presence.",
            "As a vaccine component to elicit an immune response against the spike protein.",
            "As a gene therapy vector to deliver antiviral genes into infected cells.",
            "As a small molecule drug to inhibit viral replication."
        ],
        "What engineering modifications are discussed in the paper to enhance the properties of nanobodies?": [
            "PEGylation or fusion with other proteins to improve binding and reduce clearance rates.",
            "Addition of fluorescent tags for better visualization.",
            "Incorporation of radioactive isotopes for enhanced imaging.",
            "Attachment of lipid moieties for increased membrane affinity."
        ],
        "What is the primary focus of the paper titled 'Two birds with one stone: human SIRP\u03b1 nanobodies for functional modulation and in vivo imaging of myeloid cells'?": [
            "The development of human SIRP\u03b1-specific nanobodies for therapeutic and diagnostic applications.",
            "The creation of vaccines targeting the SIRP\u03b1/CD47 interaction in tumors.",
            "The use of CRISPR technology to edit myeloid cell genes for cancer therapy.",
            "The development of small molecule inhibitors for SIRP\u03b1 modulation."
        ],
        "What issue does the paper address regarding cross-reactivity in the context of nanobody development?": [
            "Cross-reactivity with other SIRP family members and allelic variants.",
            "Cross-reactivity with unrelated viral proteins.",
            "Cross-reactivity with bacterial antigens.",
            "Cross-reactivity with plant-derived proteins."
        ],
        "What method was used in the study to select high-affinity nanobodies against specific domains of SIRP\u03b1?": [
            "Phage display library.",
            "CRISPR-Cas9 screening.",
            "Yeast two-hybrid system.",
            "RNA interference (RNAi) screening."
        ]
    }
}